---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-044938"
form_type: "8-K"
ticker: null
cik: "0001008848"
company_name: "Acorda Therapeutics, Inc."
filed_at: "2024-04-17T23:59:59+00:00"
generated_at: "2026-06-03T21:26:08.101072+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Acorda Therapeutics delisted from Nasdaq, now trades OTC Pink under ACORQ after Chapter 11

## Summary
- Common stock ceased trading on Nasdaq on April 12, 2024; now quoted on OTC Pink Open Market under ACORQ.
- Delisting triggered by failure to comply with Nasdaq Listing Rules 5101, 5110(b), and 5450(b)(1)(A) due to Chapter 11 proceedings and stockholders' equity below $10M.
- Nasdaq will file Form 25 to remove securities from registration under Section 12(b) of the Exchange Act; delisting effective 10 days after filing.

## SEC filing metadata
- accession: 0000950170-24-044938
- form_type: 8-K
- cik: 0001008848
- company_name: Acorda Therapeutics, Inc.
- filed_at: 2024-04-17T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1008848/000095017024044938/0000950170-24-044938-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1008848/000095017024044938/acor-20240412.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-044938
- JSON: https://secwatch.observer/filing/0000950170-24-044938.json
- Plain text: https://secwatch.observer/filing/0000950170-24-044938.txt

## Key facts
- Listing & Compliance Notices
  Acorda Therapeutics, Inc. received a nasdaq delisting notice notice regarding other.
  - Exchange: nasdaq
  - Notice: delisting notice
  source text: April 15, 2024, Acorda Therapeutics, Inc. (the “Company”) issued a press release announcing that the Company’s common stock ceased trading on the Nasdaq Stock Market on April 12, 2024 and began trading on the Pink Open Market under the symbol “ACORQ.” A copy of the press release is being filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1008848/000095017024044938/0000950170-24-044938-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.